PubRank

K D Bardhan

Author PubWeight™ 95.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter 1996 3.13
2 Ranitidine and cimetidine in prevention of duodenal ulcer relapse. A double-blind, randomised, multicentre, comparative trial. Lancet 1984 3.11
3 Mortality in Barrett's esophagus: three decades of experience at a single center. Endoscopy 2012 2.67
4 The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 1999 2.64
5 Survival analysis in percutaneous endoscopic gastrostomy feeding: a worse outcome in patients with dementia. Am J Gastroenterol 2000 2.60
6 Refractory duodenal ulcer. Gut 1984 2.25
7 Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001 2.04
8 One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut 1997 2.00
9 Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut 1997 1.88
10 Emergency admissions for upper gastrointestinal disease and their relation to NSAID use. Aliment Pharmacol Ther 1997 1.86
11 Does treatment with cimetidine extended beyond initial healing of duodenal ulcer reduce the subsequent relapse rate? Br Med J (Clin Res Ed) 1982 1.69
12 Bile acid malabsorption in persistent diarrhoea. J R Coll Physicians Lond 2001 1.49
13 A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol 1986 1.46
14 Double-blind comparison of cimetidine and placebo in the maintenance of healing of chronic duodenal ulceration. Gut 1979 1.43
15 Cimetidine in "chickenpox oesophagitis". Br Med J 1978 1.39
16 Upper gastrointestinal endoscopy: its effects on patient management. Br Med J 1979 1.26
17 Intermittent treatment of duodenal ulcer with cimetidine. Br Med J 1980 1.20
18 Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention. Aliment Pharmacol Ther 2013 1.15
19 Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire? Aliment Pharmacol Ther 2004 1.15
20 Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982-2002. Aliment Pharmacol Ther 2006 1.12
21 Severe hypothermia as a result of barbiturate overdose complicated by cardiac arrest. Lancet 1968 1.11
22 Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users. Aliment Pharmacol Ther 1998 1.07
23 Insights into 'fermentonomics': evaluation of volatile organic compounds (VOCs) in human disease using an electronic 'e-nose'. J Med Eng Technol 2011 1.05
24 Six years of continuous cimetidine treatment in peptic ulcer disease: efficacy and safety. Anglo-Irish Cimetidine Long-Term Study Group. Aliment Pharmacol Ther 1988 1.04
25 Percutaneous endoscopic gastrostomy: an effective strategy for gastrostomy feeding in patients with dementia. Clin Med 2004 1.03
26 Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group. Ital J Gastroenterol Hepatol 1998 1.03
27 Evaluation of gut bacterial populations using an electronic e-nose and field asymmetric ion mobility spectrometry: further insights into 'fermentonomics'. J Med Eng Technol 2012 1.01
28 Intravenous sedation for upper gastrointestinal endoscopy: diazepam versus midazolam. Br Med J (Clin Res Ed) 1984 1.01
29 Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest in erosive GERD. Digestion 2004 0.95
30 Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group. Aliment Pharmacol Ther 1998 0.95
31 Colonic fermentation--more than meets the nose. Med Hypotheses 2009 0.93
32 Characterisation of the haemodynamics of the superior mesenteric artery. J Biomech 2006 0.92
33 Studies on the gastric mucosal microcirculation. 2. Helicobacter pylori water soluble extracts induce platelet aggregation in the gastric mucosal microcirculation in vivo. Gut 1997 0.91
34 Tonsillar metastasis: A rare presentation of gastric carcinoma. Eur J Surg Oncol 2001 0.91
35 Giant gastric ulcer: its natural history and outcome in the H2RA era. Am J Gastroenterol 1999 0.91
36 Percutaneous endoscopic gastrostomy: a prospective audit of the impact of guidelines in two district general hospitals in the United Kingdom. Am J Gastroenterol 2002 0.91
37 Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: a randomized, double-blind, multi-centre trial of omeprazole with or without clarithromycin. Aliment Pharmacol Ther 1995 0.90
38 Duodenal and antral mucosal prostaglandin E2 synthesis in a study of normal subjects and all stages of duodenal ulcer disease treated by H2 receptor antagonists. Gut 1989 0.89
39 Electrical bioimpedance readings increase with higher pressure applied to the measuring probe. Physiol Meas 2005 0.88
40 Studies on gastric mucosal microcirculation. 1. The nature of regional variations induced by ethanol injury. Gut 1997 0.88
41 Toxigenic Helicobacter pylori induces changes in the gastric mucosal microcirculation in rats. Gut 2002 0.87
42 Three computer models for the calculation of prevalence of peptic ulcer disease during long-term treatment. Aliment Pharmacol Ther 1988 0.86
43 Mechanisms of Helicobacter pylori-induced rat gastric mucosal microcirculatory disturbances in vivo. Dig Dis Sci 2000 0.86
44 Virtual biopsies in Barrett's esophagus using an impedance probe. Ann N Y Acad Sci 1999 0.86
45 An assessment of the radial diffusion method for the measurement of pepsin in gastric secretion and its comparison with the haemoglobin substrate colorimetric method. Clin Chim Acta 1978 0.86
46 A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years. Aliment Pharmacol Ther 2003 0.85
47 Reduced tissue type plasminogen activator activity of the gastroduodenal mucosa in peptic ulcer disease. Gut 1993 0.84
48 Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine. Gut 1993 0.84
49 Mini-dose (1-microCi) 14C-urea breath test for the detection of Helicobacter pylori. Am J Gastroenterol 1994 0.84
50 The safety and efficacy of ranitidine bismuth citrate in combination with antibiotics for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1996 0.83
51 Low dose maintenance treatment with cimetidine in duodenal ulcer: intermediate-term results. Postgrad Med J 1986 0.83
52 Clinical trial of deglycyrrhizinised liquorice in gastric ulcer. Gut 1978 0.83
53 Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1999 0.82
54 Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection. BMJ 1997 0.82
55 Simplified technique of immuno-electrophoretic assay of human intrinsic factor on acrylamide gel. Gut 1966 0.82
56 Pathophysiological effects of long-term acid suppression in man. Dig Dis Sci 1995 0.82
57 Determination of the relationship between the pH and conductivity of gastric juice. Physiol Meas 1996 0.81
58 Intestinal secretory and absorptive function in Trichinella spiralis mouse model of postinfective gut dysfunction: role of bile acids. Gut 2007 0.81
59 Mechanisms underlying mechanosensitivity of mesenteric afferent fibers to vascular flow. Am J Physiol Gastrointest Liver Physiol 2007 0.81
60 Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest in erosive GERD. Digestion 2007 0.81
61 Maintenance treatment with cimetidine in peptic ulcer disease for up to 4 years. Scand J Gastroenterol 1987 0.81
62 Assessing the conditions for in vivo electrical virtual biopsies in Barrett's oesophagus. Med Biol Eng Comput 2000 0.81
63 A comparison of two methods for the immunoassay of intrinsic factor. J Clin Pathol 1967 0.80
64 Effects of aspirin and indomethacin on endothelial cell proliferation in vitro. J Gastroenterol Hepatol 2003 0.80
65 Electronic nose versus canine nose: clash of the titans. Gut 2011 0.80
66 Effects of chronic administration of Helicobacter pylori extracts on rat gastric mucosal microcirculation in vivo. Dig Dis Sci 2000 0.80
67 L-Arginine protects and exacerbates ethanol-induced rat gastric mucosal injury. J Gastroenterol Hepatol 2000 0.79
68 Mesenteric afferent nerves are sensitive to vascular perfusion in a novel preparation of rat ileum in vitro. Am J Physiol Gastrointest Liver Physiol 2002 0.79
69 Low frequency electrical bioimpedance for the detection of inflammation and dysplasia in Barrett's oesophagus. Physiol Meas 2003 0.79
70 No clinical benefit of adding cisapride to pantoprazole for treatment of gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2001 0.78
71 Pseudomembranous esophagitis. Gastrointest Endosc 2001 0.78
72 Alternatives to Bayes? A quantitative comparison with rule-based diagnostic inference. Methods Inf Med 1980 0.78
73 Blocking and binding autoantibody to intrinsic factor. Lancet 1968 0.78
74 Mucosal plasminogen activator activity in peptic ulcer disease. Ann N Y Acad Sci 1992 0.77
75 Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire? Digestion 2007 0.77
76 Dietary phosphilipids and sterols protective against peptic ulceration. Phytother Res 2012 0.77
77 Can the H2 receptor antagonists change the natural history of duodenal ulcer disease? Am J Gastroenterol 1994 0.77
78 Effect of longterm misoprostol coadministration with non-steroidal anti-inflammatory drugs: a histological study. Gut 1995 0.77
79 Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease. Pharmacoeconomics 1999 0.77
80 Duodenal mucosal histology and histochemistry in active, treated and healed duodenal ulcer: correlation with duodenal prostaglandin E2 production. J Gastroenterol Hepatol 1996 0.77
81 Omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1999 0.77
82 Mast cell stabilization prevents ethanol-induced rat gastric mucosal injury: mechanisms of protection. J Gastroenterol Hepatol 2000 0.77
83 Can electrical impedance tomography be used to detect gastro-oesophageal reflux? Physiol Meas 1996 0.77
84 Breathomics-exhaled volatile organic compound analysis to detect hepatic encephalopathy: a pilot study. J Breath Res 2016 0.77
85 Efficacy of rabeprazole once daily for acid-related disorders. Dig Dis Sci 2001 0.76
86 Antral mucosal cytokine gene expression in Helicobacter pylori infection and duodenal ulcer disease. Scand J Gastroenterol 1997 0.75
87 Effect of transport medium and transportation time on culture of Helicobacter pylori from gastric biopsy specimens. J Clin Pathol 1995 0.75
88 Referral of Dr. Peter Mansfield to the GMC. Doctors seem to have to march in step. BMJ 2001 0.75
89 Reply to Schoppman et al. Endoscopy 2013 0.75
90 Mast cells and gastric mucosal damage: yet another mechanism of injury? J Gastroenterol Hepatol 1998 0.75
91 Oesophageal acid-peptic strictures in the histamine H2 receptor antagonist and proton pump inhibitor era. Dig Liver Dis 2003 0.75
92 Unfavourable results and drug company trials. Lancet 1987 0.75
93 Continuous 24 hour ambulatory monitoring of intragastric pH in man. Clin Phys Physiol Meas 1987 0.75
94 [Ranitidine and cimetidine in the prevention of recurrence of duodenal ulcer. A randomized, double-blind, multicenter comparative study]. Fortschr Med 1985 0.75
95 The scars of time: the disappearance of peptic ulcer-related pyloric stenosis through the 20th century. J R Coll Physicians Edinb 2014 0.75
96 Duodenal erosions during cimetidine therapy. Lancet 1979 0.75
97 Identifying oesophageal contents using electrical impedance tomography. Physiol Meas 1995 0.75
98 The management of refractory gastric ulcer using H2-receptor antagonists. Aliment Pharmacol Ther 1996 0.75
99 Bile acid malabsorption associated with Graves' disease. J Clin Gastroenterol 1994 0.75
100 Cimetidine or vagotomy? Br J Surg 1984 0.75
101 What I would say to the Royal Commission. Suggestions for reform. Br Med J 1976 0.75
102 Detecting oesophageal-related changes using electrical impedance tomography. Physiol Meas 1995 0.75
103 Upper gastrointestinal endoscopy. Br Med J 1979 0.75
104 Duodenal ulcer healing rates in a one-year follow-up study with ranitidine bismuth citrate and antibiotics. Hepatogastroenterology 2002 0.75
105 Cimetidine withdrawal. Lancet 1977 0.75
106 Proceedings: Deglycyrrhizinated liquorice in gastric ulcer: a double blind controlled study. Gut 1976 0.75
107 Effect of cimetidine on surgery for duodenal ulcer. Lancet 1981 0.75
108 Effects of on-line symptom-processing on history-taking and diagnosis--a simulation study. Int J Biomed Comput 1979 0.75
109 Midazolam and flumazenil in gastroenterology. Acta Anaesthesiol Scand Suppl 1990 0.75
110 High Helicobacter pylori eradication rate with a 1-week regimen containing ranitidine bismuth citrate. Aliment Pharmacol Ther 1998 0.75
111 Sedation for upper gastrointestinal endoscopy. Br J Anaesth 1981 0.75
112 Atypical presentation of Crohn's disease: severe, recurrent iron deficiency anemia dependent on blood transfusions. Am J Gastroenterol 1994 0.75
113 Cerebellar syndrome after nitrazepam overdosage. Lancet 1969 0.75
114 Drinking and smoking when taking H2-antagonists. Lancet 1985 0.75